These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32434753)

  • 1. Medicines with one seller and many buyers: strategies to increase the power of the payer.
    Rintoul A; Colbert A; Garner S; Kotwani A; Vogler S; Bouvy J; Hill A
    BMJ; 2020 May; 369():m1705. PubMed ID: 32434753
    [No Abstract]   [Full Text] [Related]  

  • 2. Sources of Innovation in Gene Therapies - Approaches to Achieving Affordable Prices.
    Vokinger KN; Avorn J; Kesselheim AS
    N Engl J Med; 2023 Jan; 388(4):292-295. PubMed ID: 36688504
    [No Abstract]   [Full Text] [Related]  

  • 3. Clients' ability to pay.
    Vet Rec; 2014 Jan; 174 Suppl 1():9. PubMed ID: 24470623
    [No Abstract]   [Full Text] [Related]  

  • 4. Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries.
    Elek P; Takács E; Merész G; Kaló Z
    Health Policy Plan; 2017 Apr; 32(3):349-358. PubMed ID: 27697777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value in Health: How It Is Defined and Used in Priority Setting and Pricing in Norway.
    Melberg HO
    Healthc Pap; 2019 Oct; 18(3):22-28. PubMed ID: 31642804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of importing prescription medications from lower-income countries.
    Dhalla IA; Detsky AS
    JAMA; 2008 Sep; 300(12):1453-5. PubMed ID: 18812537
    [No Abstract]   [Full Text] [Related]  

  • 7. Share of the pet care market.
    Vet Rec; 2014 Jan; 174 Suppl 1():8. PubMed ID: 24470621
    [No Abstract]   [Full Text] [Related]  

  • 8. Federal Trade Commission and the Department of Justice come out in favor of competition in health care.
    Werling K; Foltushansky S
    Health Care Law Mon; 2004 Oct; ():8-14. PubMed ID: 15524221
    [No Abstract]   [Full Text] [Related]  

  • 9. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 10. Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results.
    Dervaux B; Baseilhac E; Fagon JY; ; Biot C; Blachier C; Braun E; Debroucker F; Detournay B; Ferretti C; Granger M; Jouan-Flahault C; Lussier MD; Meyer A; Muller S; Pigeon M; De Sahb R; Sannié T; Sapède C; Vray M
    Therapie; 2014; 69(4):323-8. PubMed ID: 25230355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of studies reporting actual prices for medicines.
    Mardetko N; Kos M; Vogler S
    Expert Rev Pharmacoecon Outcomes Res; 2019 Apr; 19(2):159-179. PubMed ID: 30468097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economics of parallel trade.
    Danzon PM
    Pharmacoeconomics; 1998 Mar; 13(3):293-304. PubMed ID: 10178655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics and economics of pharmaceutical pricing.
    Parker-Lue S; Santoro M; Koski G
    Annu Rev Pharmacol Toxicol; 2015; 55():191-206. PubMed ID: 25149920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 16. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 17. Competition and regulation: the consumer choice health plan alternative.
    Ackerman FK
    Med Group Manage; 1980; 27(4):58-64. PubMed ID: 10247677
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicine for all?
    Curry K
    Am J Nurs; 2004 Jun; 104(6):13; author reply 13-14. PubMed ID: 15187589
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA chief attacks Canada's drug price controls.
    Webster P
    Lancet; 2003 Nov; 362(9398):1816. PubMed ID: 14661624
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovation in Hospital Revenues: Developing Retail Sales Channels.
    Wright EW; Marvel J; Wright MK
    Health Care Manag (Frederick); 2018; 37(1):47-54. PubMed ID: 29266085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.